These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1622907)

  • 21. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.
    Tohgi H; Tamura K; Kimura B; Kimura M; Suzuki H
    Stroke; 1988 Jun; 19(6):700-3. PubMed ID: 3376161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.
    Dabaghi SF; Kamat SG; Payne J; Marks GF; Roberts R; Schafer AI; Kleiman NS
    Am J Cardiol; 1994 Oct; 74(7):720-3. PubMed ID: 7942533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot trial of the effects of low-dose acetylsalicylic acid on platelet thromboxane B2 production.
    Janssen PL; Akkerman JW; Hollman PC; van Staveren WA; Zwaginga JJ; Katan MB
    Eur J Clin Nutr; 1995 May; 49(5):365-70. PubMed ID: 7664723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
    Ayala DE; Ucieda R; Hermida RC
    Chronobiol Int; 2013 Mar; 30(1-2):260-79. PubMed ID: 23004922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.
    Rotchell YE; Cruickshank JK; Gay MP; Griffiths J; Stewart A; Farrell B; Ayers S; Hennis A; Grant A; Duley L; Collins R
    Br J Obstet Gynaecol; 1998 Mar; 105(3):286-92. PubMed ID: 9532988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
    Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
    Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term ultra-low-dose aspirin therapy and platelet function.
    Chetty N; Atkinson PM; Bradlow BA
    S Afr Med J; 1985 Aug; 68(5):307-9. PubMed ID: 3929399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia.
    Steyn DW; Odendaal HJ
    Lancet; 1997 Nov; 350(9087):1267-71. PubMed ID: 9357405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects.
    Jermany J; Branson J; Schmouder R; Guillaume M; Rordorf C
    J Clin Pharmacol; 2005 Oct; 45(10):1172-8. PubMed ID: 16172182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.
    Spitz B; Magness RR; Cox SM; Brown CE; Rosenfeld CR; Gant NF
    Am J Obstet Gynecol; 1988 Nov; 159(5):1035-43. PubMed ID: 3189434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single oral dose study of two isosorbide-based aspirin prodrugs in the dog.
    Gilmer JF; Murphy MA; Shannon JA; Breen CG; Ryder SA; Clancy JM
    J Pharm Pharmacol; 2003 Oct; 55(10):1351-7. PubMed ID: 14607016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose aspirin: selective inhibition of rectal dialysis thromboxane B2 in healthy volunteers.
    Cole AT; Filipowicz B; Hyman-Taylor P; Hawkey CJ
    Aliment Pharmacol Ther; 1994 Oct; 8(5):521-6. PubMed ID: 7865644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antiplatelet effect of daily low dose enteric-coated aspirin in man: a time course of onset and recovery.
    Vanags D; Rodgers SE; Lloyd JV; Bochner F
    Thromb Res; 1990 Sep; 59(6):995-1005. PubMed ID: 2264023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease.
    Qayyum R; Becker DM; Yanek LR; Moy TF; Becker LC; Faraday N; Vaidya D
    Am J Cardiol; 2008 May; 101(9):1359-63. PubMed ID: 18435972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.